Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge

International Journal of Infectious Diseases(2020)10.1016/j.ijid.2020.07.023Source: DataRank Database

Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge is a research paper published in International Journal of Infectious Diseases (2020). On theSindex it has a DataRank of 0. It has been cited 67 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access67 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 1.57)OA: goldTopics (64)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (17)

Anahita Mostaghim,Catherine Bielick ORCID,Angela McLaughlin ORCID,Davidson H. Hamer ORCID,Lee M. Wetzler ORCID

Live enrichment

PubMed:32721528 PMC:PMC7591937 OpenAlex:https://openalex.org/W3044965497

NIAID NIH HHS

Grant: K24 AI145661

NIAID NIH HHS

Grant: T32 AI052074

NIAID NIH HHS

Grant: P30 AI042853

NIA NIH HHS

Grant: R01 AG060890

National Institutes of Health

Grant: 5T32AI052074-13

BU Clinical HIV/AIDS Research Training Program

National Institutes of Health

Grant: 5K24AI145661-02

HIV-1 mucosal transmission and persistence

National Institutes of Health

FWCI

1.57

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

2024

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.ijid.2020.07.023

publisherhttps://doi.org/10.1016/j.ijid.2020.07.023

publisherhttps://api.elsevier.com/content/article/PII:S1201971220305683?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1201971220305683?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32721528

Fields of Study

COVID-19 Clinical Research StudiesRespiratory Support and MechanismsSARS-CoV-2 and COVID-19 Research0301 basic medicine03 medical and health sciences0303 health sciences

MeSH Terms

BetacoronavirusCOVID-19SARS-CoV-2Interleukin-6 InhibitorsFemaleHumansIntubation, IntratrachealMaleMiddle AgedPatient DischargePneumonia, ViralInterleukin-6Treatment OutcomeCoronavirus InfectionsPandemicsAntibodies, Monoclonal, Humanized

Keywords

MedicineHazard ratioTocilizumabConfidence intervalStage (stratigraphy)Fraction of inspired oxygenCoronavirus disease 2019 (COVID-19)IntubationClinical endpointInternal medicineObservational studyRandomized controlled trialAnesthesiaGastroenterologySurgeryDiseaseMechanical ventilationCytokine Release SyndromeSarilumabInterleukin-6 InhibitorsCovid-19Microbiology (medical)MalePneumonia, ViralInfectious and parasitic diseasesRC109-216Antibodies, Monoclonal, HumanizedArticleBetacoronavirusSíndrome respiratorio agudo graveIntubation, IntratrachealHumansPandemicsSARS-CoV-2General MedicineMiddle AgedPatient DischargeCoronavirusInfectious DiseasesTreatment OutcomeFemaleCoronavirus Infections

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being